π Indian companies are shifting focus in global buys
Sun Pharmaceutical Industries acquired US-based Organon in July, marking a major overseas deal for an Indian company. This transaction took place in the US, and the deal was part of a broader trend in India Inc. Companies are now prioritizing AI and IP over just buying scale to drive growth. This strategic shift reflects stronger financial health and changing global market conditions. π